{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_topology","feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","contains":"claims, sources, anecdotes, question_graph slice","slug":"pt-141-gabapentin","urls":{"read":"https://miscsubjects.com/api/articles/pt-141-gabapentin/topology"},"how_to_use":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/pt-141-gabapentin/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/pt-141-gabapentin/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"graph_topology","name":"Cross-article graph","what":"Merged claims/sources across condition+stack slugs for one question.","urls":{"read":"https://miscsubjects.com/api/articles/pt-141-gabapentin/graph-topology?question=..."}},{"id":"question_graph","name":"Question graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output).","urls":{"read":"https://miscsubjects.com/api/articles/pt-141-gabapentin/question-graph","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/pt-141-gabapentin/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","why":"Every feature is auditable collective intelligence","how":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/pt-141-gabapentin/topology"},"imessage":null,"router":null,"related":[{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"graph_topology","what":"Merged claims/sources across condition+stack slugs for one question."},{"id":"question_graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output)."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."}],"not_medical_advice":true},"slug":"pt-141-gabapentin","title":"PT-141 and Gabapentin: Evidence-Graded Look at Sexual Arousal Pathways","register":"source_ledger","tags":["peptide","matrix"],"updated_at":"2026-07-17T02:41:05.815Z","body_excerpt":"## What's breaking down if you have Gabapentin / pregabalin\n\nGabapentin and pregabalin bind voltage-gated calcium channels. This reduces excitatory neurotransmitter release in the central and peripheral nervous system. The primary intended effect is dampening of neuropathic pain signals. A documented side effect profile includes reduced sexual desire, genital numbness, difficulty achieving orgasm, and lowered arousal in some users. These changes occur because the same calcium-channel modulation can blunt sensory and central pathways involved in sexual response. No structural nerve degeneration is proven from the drug itself in standard use, but the functional suppression of signals can persist as long as the medication is taken. This creates a trade-off: pain signal reduction without repair of the underlying nerve issue, and potential added suppression in arousal circuits.\n\n## Why PT-141 might help you\n\n1. You are reading about Gabapentin / pregabalin — what breaks down matters before any compound name.\n2. Therefore for you: If reduced sexual desire or arousal forms part of your experience on these medications, PT-141 is discussed because it acts on melanocortin receptors (primarily MC3R and MC4R) in the hypothalamus and other CNS regions to promote sexual motivation and genital arousal responses.\n3. The mechanism is central nervous system activation of desire pathways rather than peripheral vasodilation alone. If your gabapentin-related numbness or low drive stems from suppressed excitatory signaling, this targeted arousal pathway engagement addresses a different layer than simple signal masking.\n4. Human data on the approved use show measurable increases in sexual desire scores and reduced distress in premenopausal women with hypoactive sexual desire disorder. No trials test PT-141 specifically against gabapentin-induced changes, so any benefit remains extrapolated from the shared CNS arousal domain.\n\n## Why Gabapentin / pregabalin matters for you\n\nDrug: Gabapentin / pregabalin.\nWhat it does: Masks neuropathic pain signal; does not repair nerve.\nTherefore for you: The drug suppresses a signal (excitatory transmission) to reduce pain perception. This suppression can extend to sexual sensory and motivational pathways, creating a functional trade-off where pain relief comes with potential loss of arousal function. It does not support tissue repair or reverse nerve changes; it manages symptoms. For someone whose primary concern includes both pain and sexual side effects, the drug reduces one load while potentially adding another in the arousal domain.\n\n## How these fit together\n\nSingle-compound focus — PT-141 targets sexual / CNS arousal. Gabapentin / pregabalin primarily suppresses pain signals. The two operate on distinct layers: one dampens broad excitatory transmission, the other activates specific melanocortin-mediated desire circuits. No synergy data exist. Any combined use would address separate functional domains without documented interaction or additive repair effects.\n\n## What the evidence actually shows\n\nHuman trials exist for PT-141 (bremelanotide) in hypoactive sexual desire disorder. Phase 3 RECONNECT studies (women) demonstrated statistically significant improvements in desire and reduced distress versus placebo when used on-demand. FDA approval followed in 2019 for premenopausal women. Separate smaller trials and reviews report erectile response in men with ED, including some diabetic cohorts, with positive clinical results in roughly one-third of participants versus under 10% on placebo. No randomized human trials examine PT-141 in people taking gabapentin or pregabalin. No preclinical (rat) studies directly test the combination. Evidence inventory: multiple human trials for the approved indication (tier: human); mechanistic understanding of melanocortin action (tier: mechanistic); zero direct data on the gabapentin cross (tier: speculative for this specific pairing).\n\n## What scientists say\n\nPublished reviews ","ranking":"safety-first (interaction_risk/limitations), then quote-gated effective_weight","claims":[{"id":"c2","text":"PT-141 activates melanocortin receptors in the CNS to promote sexual desire and arousal; FDA-approved for HSDD in premenopausal women based on Phase 3 trials showing improved desire scores.","tier":"human","weight":0.8,"section":"Why PT-141 might help you","slot":null,"interaction_risk":false,"status":"active","source_ids":["s0","s2","s15"],"source_status":"sourced","why_material":"Core human evidence for the arousal pathway PT-141 targets.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c1","text":"Gabapentin and pregabalin reduce excitatory neurotransmitter release via calcium channel binding, which can extend to sexual arousal pathways causing numbness or reduced desire.","tier":"mechanistic","weight":0.3,"section":"What's breaking down if you have Gabapentin / pregabalin","slot":null,"interaction_risk":false,"status":"active","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes the functional suppression layer relevant to the PT-141 cross.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c4","text":"Reddit users report gabapentin causing sexual numbness and anorgasmia; one anecdote notes positive PT-141 response while on gabapentin.","tier":"anecdotal","weight":0.3,"section":"What people say on Reddit","slot":null,"interaction_risk":false,"status":"active","source_ids":["s24"],"source_status":"sourced","why_material":"Documents user experiences without claiming causation or efficacy.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c3","text":"No randomized trials test PT-141 with gabapentin or pregabalin; any benefit for drug-related sexual effects is extrapolated.","tier":"speculative","weight":0.1,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":[],"source_status":"unsourced","why_material":"Clarifies the evidence gap for this specific pairing.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.1,"quote_gated":false}],"sources":[{"id":"s0","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8788464/","title":"Bremelanotide for Treatment of Female Hypoactive Sexual Desire Disorder","quote":"Bremelanotide (PT-141) is a melanocortinergic agent... demonstrated efficacy in improving male and female sexual function.","summary":"Review of bremelanotide mechanism and trials.","claim_ids":["c2"],"link_status":"ok","quote_status":"unverified","hash":"163ee5c797570dbb4b272b7b073a7be113ba2b5bd8bb8e399dae4f28f7ee1281"},{"id":"s1","type":"medical","url":"https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805","title":"Bremelanotide (subcutaneous route)","quote":"Bremelanotide injection is used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women.","summary":"Official indication and dosing info.","claim_ids":["c1"],"link_status":"http_403","quote_status":"unverified","hash":"5c54b9448c181a07edab2c2e64df65cf7548cf8cf1e3549ab7c88ac46e8941e4"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6819023/","title":"Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder","quote":"The efficacy and safety of bremelanotide, taken as needed over 24 weeks, demonstrated statistically significant and clinically meaningful improvements in low sexual desire.","summary":"24-week human data on efficacy.","claim_ids":["c2"],"link_status":"ok","quote_status":"unverified","hash":"80509c041d36594f391bbdee73e06d91a2907b5fd61c336fb916f8936be265e5"},{"id":"s15","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6819023/","title":"Long-Term Safety and Efficacy of Bremelanotide","quote":"statistically significant and clinically meaningful improvements","summary":"Confirms Phase 3 outcomes.","claim_ids":["c2"],"link_status":"ok","quote_status":"verified","hash":"a519c623e0b8c2c242f8bc1b3d965f1c1c37b0f0bdb0a6d65e02b5e866b5b731"},{"id":"s24","type":"reddit","url":"https://www.reddit.com/r/Menopause/comments/pbczcc/vyleesi_for_libido_update_after_1st_injection/","title":"Vyleesi for libido - UPDATE after 1st injection","quote":"Gabapentin made me numb and organism impossible... the yawning and stretching is a sign Vyleesi is starting to work","summary":"User reports linking gabapentin side effects and PT-141 experience.","claim_ids":["c4"],"link_status":"ok","quote_status":"unverified","hash":"0c256f6411fb4a11a0cf3ab4ea58b81e8ed8fd206e3c572b393d80c9d9869896"}],"anecdotal_sources":[{"id":"s24","type":"reddit","url":"https://www.reddit.com/r/Menopause/comments/pbczcc/vyleesi_for_libido_update_after_1st_injection/","title":"Vyleesi for libido - UPDATE after 1st injection","quote":"Gabapentin made me numb and organism impossible... the yawning and stretching is a sign Vyleesi is starting to work","summary":"User reports linking gabapentin side effects and PT-141 experience.","claim_ids":["c4"],"link_status":"ok","quote_status":"unverified","hash":"0c256f6411fb4a11a0cf3ab4ea58b81e8ed8fd206e3c572b393d80c9d9869896"}],"scientific_sources":[{"id":"s0","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8788464/","title":"Bremelanotide for Treatment of Female Hypoactive Sexual Desire Disorder","quote":"Bremelanotide (PT-141) is a melanocortinergic agent... demonstrated efficacy in improving male and female sexual function.","summary":"Review of bremelanotide mechanism and trials.","claim_ids":["c2"],"link_status":"ok","quote_status":"unverified","hash":"163ee5c797570dbb4b272b7b073a7be113ba2b5bd8bb8e399dae4f28f7ee1281"},{"id":"s1","type":"medical","url":"https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805","title":"Bremelanotide (subcutaneous route)","quote":"Bremelanotide injection is used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women.","summary":"Official indication and dosing info.","claim_ids":["c1"],"link_status":"http_403","quote_status":"unverified","hash":"5c54b9448c181a07edab2c2e64df65cf7548cf8cf1e3549ab7c88ac46e8941e4"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6819023/","title":"Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder","quote":"The efficacy and safety of bremelanotide, taken as needed over 24 weeks, demonstrated statistically significant and clinically meaningful improvements in low sexual desire.","summary":"24-week human data on efficacy.","claim_ids":["c2"],"link_status":"ok","quote_status":"unverified","hash":"80509c041d36594f391bbdee73e06d91a2907b5fd61c336fb916f8936be265e5"},{"id":"s15","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6819023/","title":"Long-Term Safety and Efficacy of Bremelanotide","quote":"statistically significant and clinically meaningful improvements","summary":"Confirms Phase 3 outcomes.","claim_ids":["c2"],"link_status":"ok","quote_status":"verified","hash":"a519c623e0b8c2c242f8bc1b3d965f1c1c37b0f0bdb0a6d65e02b5e866b5b731"}],"user_reports":[],"related_articles":[],"question_graph":{"slug":"pt-141-gabapentin","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"honesty":{"active_claims":4,"retracted_claims":0,"cut_claims":0,"challenges":0,"scrub_events":0,"note":"Retracted/cut claims stay on ledger but are excluded from ask unless ?include_inactive=1"},"counts":{"claims":4,"claims_total":4,"sources":5,"anecdotal":1,"scientific":4,"user_reports":0,"questions":0,"evidence_ingests":0}}